Susquehanna International Group’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $649K | Sell |
|
|||||
|
2025
Q2 | $837K | Buy |
|
|||||
|
2025
Q1 | $729K | Buy |
|
|||||
|
2024
Q4 | $401K | Buy |
|
|||||
|
2024
Q3 | $391K | Sell |
|
|||||
|
2024
Q2 | $938K | Buy |
|
|||||
|
2024
Q1 | $643K | Sell |
|
|||||
|
2023
Q4 | $1.02M | Sell |
|
|||||
|
2023
Q3 | $2.69M | Buy |
|
|||||
|
2023
Q2 | $559K | Sell |
|
|||||
|
2023
Q1 | $634K | Buy |
|
|||||
|
2022
Q4 | $166K | Sell |
|
|||||
|
2022
Q3 | $531K | Buy |
|
|||||
|
2022
Q2 | $132K | Sell |
|
|||||
|
2022
Q1 | $667K | Sell |
|
|||||
|
2021
Q4 | $1.78M | Buy |
|
|||||
|
2021
Q3 | $728K | Buy |
|
|||||
|
2021
Q2 | $563K | Sell |
|
|||||
|
2021
Q1 | $683K | Buy |
|
|||||
|
2020
Q4 | $301K | Sell |
|
|||||
|
2020
Q3 | $516K | Sell |
|
|||||
|
2020
Q2 | $722K | Sell |
|
|||||
|
2020
Q1 | $1.09M | Buy |
|
|||||
|
2019
Q4 | $495K | Sell |
|
|||||
|
2019
Q3 | $942K | Sell |
|
|||||
|
2019
Q2 | $1.47M | Sell |
|
|||||
|
2019
Q1 | $3.23M | Buy |
|
|||||
|
2018
Q4 | – | Hold |
|
|||||
|
2018
Q3 | – | Hold |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $316K | Sell |
|
|||||
|
2017
Q4 | $417K | Buy |
|
|||||
|
2017
Q3 | – | Hold |
|
|||||
|
2017
Q2 | – | Hold |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $1.61M | Sell |
|
|||||
|
2016
Q3 | $2.53M | Buy |
|
|||||
|
2016
Q2 | $1.31M | Buy |
|
|||||
|
2016
Q1 | $96K | Sell |
|
|||||
|
2015
Q4 | $531K | Sell |
|
|||||
|
2015
Q3 | $799K | Buy |
|
|||||
|
2015
Q2 | $678K | Sell |
|
|||||
|
2015
Q1 | $1.51M | Buy |
|
|||||
|
2014
Q4 | $274K | Sell |
|
|||||
|
2014
Q3 | $704K | Sell |
|
|||||
|
2014
Q2 | $1.43M | Sell |
|
|||||
|
2014
Q1 | $1.49M | Sell |
|
|||||
|
2013
Q4 | $2.98M | Buy |
|
|||||
|
2013
Q3 | – | Sell |
|
|||||
|
2013
Q2 | $1.04M | Buy |
|